Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-516.77M
↓ 239% vs avg
Percentile
P0
Near historical low
Streak
9 yr
Consecutive declineContracting
Average
$-152.65M
Historical baseline
PeriodValueYoY Change
TTM$-516.77M-52.5%
2024$-338.85M-52.2%
2023$-222.61M-32.6%
2022$-167.88M-55.9%
2021$-107.70M-43.7%
2020$-74.95M-39.2%
2019$-53.83M-87.5%
2018$-28.71M-214.6%
2017$-9.13M-51.0%
2016$-6.04M-